This article was originally published on TipRanks.com Pharmaceutical and biotechnology company AstraZeneca plc (AZN) recently revealed that its long-acting antibody (LAAB) combination, EVUSHELD, has received emergency …
This article was originally published on TipRanks.com AstraZeneca (AZN) has been exploring a string of options, key among them the listing of a …
AstraZeneca (AZN) has revealed positive Phase IIa data from the EPICCURE trial of its injection AZD8601, which has been co-developed with Moderna (MRNA). The …
Shares of AstraZeneca (AZN) declined 3.3% in Friday’s early hours, even though the global pharmaceutical company reported better-then-expected earnings for the third quarter.
The South Korean government is in talks with Moderna (MRNA) and Pfizer (PFE) about manufacturing their COVID-19 vaccines in the country, according to …
AstraZeneca (AZN) is collaborating with biotech company Alchemab on prostate cancer research. The two companies will work on a proof-of-concept study to develop …
AstraZeneca (AZN) has received approval from the U.S.
AstraZeneca announced yesterday that the World Health Organization (WHO) has granted an Emergency Use Listing (EUL) for its COVID-19 vaccine. The authorization permits …
The new coronavirus mutant strains are playing havoc with the already approved Covid-19 vaccines. The latest data shows AstraZeneca’s (AZN) vaccine, AZD1222 is …
The Astrazeneca/Oxford vaccine offers only limited protection against mild disease caused by the South African variant of the coronavirus, according to a Financial Times report, …
